Study title:
Mamelak-A-N, Prados-M-D, Obana-W-G, Cogen-P-H, Edwards-M-S-B.
Department of Neurological Surgery, c/o The Editorial Office, 1360
Ninth Avenue, San Francisco, CA 94122, United States.
Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma.
Journal of Neurosurgery {J-NEUROSURG}, 1994, Vol/Iss/Pg. 81/1 (24-30) , ISSN: 0022-3085.
Mamelak-A-N, Prados-M-D, Obana-W-G, Cogen-P-H, Edwards-M-S-B.
Department of Neurological Surgery, c/o The Editorial Office, 1360
Ninth Avenue, San Francisco, CA 94122, United States.
Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma.
Journal of Neurosurgery {J-NEUROSURG}, 1994, Vol/Iss/Pg. 81/1 (24-30) , ISSN: 0022-3085.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|